Firefly Neuroscience, Inc. (NASDAQ:AIFF) Short Interest Update

Firefly Neuroscience, Inc. (NASDAQ:AIFF) was the recipient of a large decrease in short interest during the month of September. As of September 30th, there was short interest totaling 884,200 shares, a decrease of 37.3% from the September 15th total of 1,410,000 shares. Approximately 15.0% of the company’s stock are short sold. Based on an average daily volume of 2,040,000 shares, the days-to-cover ratio is currently 0.4 days. Based on an average daily volume of 2,040,000 shares, the days-to-cover ratio is currently 0.4 days. Approximately 15.0% of the company’s stock are short sold.

Firefly Neuroscience Price Performance

Shares of NASDAQ:AIFF opened at $2.35 on Wednesday. The business’s 50-day moving average is $2.76 and its 200 day moving average is $2.96. Firefly Neuroscience has a 1 year low of $1.86 and a 1 year high of $17.20. The firm has a market capitalization of $31.61 million, a P/E ratio of -0.94 and a beta of 2.11.

Firefly Neuroscience (NASDAQ:AIFF) last announced its earnings results on Wednesday, August 13th. The company reported ($0.14) earnings per share (EPS) for the quarter. Firefly Neuroscience had a negative net margin of 5,335.75% and a negative return on equity of 464.02%.

Insider Buying and Selling at Firefly Neuroscience

In related news, major shareholder Windsor Private Capital Lp sold 45,036 shares of the company’s stock in a transaction on Friday, October 17th. The stock was sold at an average price of $2.55, for a total transaction of $114,841.80. Following the completion of the sale, the insider directly owned 1,367,526 shares in the company, valued at $3,487,191.30. This represents a 3.19% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. In the last three months, insiders sold 269,247 shares of company stock worth $725,708. Corporate insiders own 6.44% of the company’s stock.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Firefly Neuroscience stock. Geode Capital Management LLC boosted its holdings in shares of Firefly Neuroscience, Inc. (NASDAQ:AIFF) by 92.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 120,604 shares of the company’s stock after buying an additional 58,067 shares during the period. Geode Capital Management LLC owned approximately 0.94% of Firefly Neuroscience worth $341,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Hedge funds and other institutional investors own 4.96% of the company’s stock.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Firefly Neuroscience in a research note on Wednesday, October 8th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company presently has a consensus rating of “Sell”.

About Firefly Neuroscience

Firefly Neuroscience, Inc, a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder.